BidaskClub cut shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a sell rating in a research note issued to investors on Wednesday.
Other equities analysts also recently issued research reports about the company. ValuEngine raised Surgery Partners from a hold rating to a buy rating in a research report on Thursday, August 9th. Zacks Investment Research raised Surgery Partners from a hold rating to a buy rating and set a $20.00 price target on the stock in a research report on Thursday, August 16th. Bank of America raised Surgery Partners from a neutral rating to a buy rating in a research report on Tuesday, September 18th. UBS Group started coverage on Surgery Partners in a research report on Thursday, November 15th. They set a neutral rating and a $15.00 price target on the stock. Finally, Leerink Swann boosted their price target on Surgery Partners from $20.00 to $25.00 and gave the stock an outperform rating in a research report on Monday, August 13th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of Buy and an average price target of $18.29.
Shares of NASDAQ SGRY opened at $13.01 on Wednesday. The company has a market cap of $628.74 million, a price-to-earnings ratio of -15.49 and a beta of 2.02. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.42 and a current ratio of 1.57. Surgery Partners has a twelve month low of $8.15 and a twelve month high of $19.95.
In other news, insider Brandan Lingle sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 28th. The stock was sold at an average price of $18.15, for a total transaction of $181,500.00. Following the completion of the sale, the insider now owns 20,393 shares in the company, valued at $370,132.95. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 8.20% of the company’s stock.
Several large investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Surgery Partners by 1.2% during the third quarter. Vanguard Group Inc. now owns 1,566,343 shares of the company’s stock worth $25,845,000 after acquiring an additional 18,336 shares during the period. Morgan Stanley boosted its holdings in shares of Surgery Partners by 12.1% during the third quarter. Morgan Stanley now owns 65,362 shares of the company’s stock worth $1,078,000 after acquiring an additional 7,034 shares during the period. Teachers Advisors LLC boosted its holdings in shares of Surgery Partners by 7.5% during the third quarter. Teachers Advisors LLC now owns 71,698 shares of the company’s stock worth $1,183,000 after acquiring an additional 5,001 shares during the period. MetLife Investment Advisors LLC boosted its holdings in shares of Surgery Partners by 55.2% during the third quarter. MetLife Investment Advisors LLC now owns 14,807 shares of the company’s stock worth $244,000 after acquiring an additional 5,267 shares during the period. Finally, Point72 Asset Management L.P. boosted its holdings in shares of Surgery Partners by 11.3% during the third quarter. Point72 Asset Management L.P. now owns 303,856 shares of the company’s stock worth $5,014,000 after acquiring an additional 30,762 shares during the period. Institutional investors own 98.90% of the company’s stock.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Further Reading: What is a bull market?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.